07:00 , Sep 4, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Schizophrenia Aminoadipate aminotransferase (AADAT; KAT2) Rat and nonhuman primate studies suggest KAT2 inhibitors could help treat schizophrenia. In rats with chemical-induced attention deficits, a selective,...